AURORA, Colo., April 27, 2023 /PRNewswire/ — Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced today that it has closed an oversubscribed Series B financing round of $58.75 million. The financing was led by Foresite Capital, with…
News
Medical campus developers discover family, WWII connections during renovations
After purchasing two buildings in February, a Chicago investor found even more to love about the project. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
Biodesix Announces Second Quarter 2024 Results and Highlights
LOUISVILLE, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the second quarter ended June 30, 2024. “The second quarter marks sustained excellence in […]
News
Denver bioscience data software startup gets $3.7M, attention from local researchers
“I realized I was getting tired of waiting for somebody to build the software I wanted to see in the lab,” said founder and CEO Rani Powers. Click here to view original post
